Sai Parenterals Limited (SAIPARENT) — Announcement | 1 July 2026

StockFin.ai

Try Free

Sai Parenterals announced its subsidiary Noumed Pharmaceuticals secured an exclusive OTC medicine supply agreement with Australia's leading pharmacy network valued at AUD 202 million (INR 1300 crores), effective 1 July 2026 for 7.5 years with a possible 3-year extension.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SAIPARENT ✨ Ask AI About This

About Sai Parenterals Limited (SAIPARENT)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹2,126.13 Cr

View full SAIPARENT stock details →

📡 Get AI alerts when SAIPARENT files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SAIPARENT — Free

💡 Ask AI about this filing

"How does this announcement affect Sai Parenterals Limited's outlook?" "What did Sai Parenterals Limited announce on 1 July 2026?" "Is this positive or negative for SAIPARENT?"

Ask AI Free →

📊 More SAIPARENT filings

See all SAIPARENT filings →

🔥 Also filed on 1 July 2026

RAMRAT Ram Ratna Wires Limited Corporate Action PSB Punjab & Sind Bank Insider Trading RELTD Ravindra Energy Limited Insider Trading RHL Robust Hotels Limited Insider Trading RELTD Ravindra Energy Limited Corporate Action ROTO Roto Pumps Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when SAIPARENT files new disclosures

Track SAIPARENT filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SAIPARENT — Free

Free account · 2 AI queries/day